← Back to search

Numen

Engineering a future without cancer deaths.

Y CombinatorSummer 2023ActiveHealthcareDiagnosticsMachine LearningBiotechHealthcareDiagnostics

What they do

Problem

Cancer causes preventable deaths due to inadequate detection and treatment.

Solution

Numen develops technology to reduce cancer mortality and enable a future without cancer deaths.

Founders

Luca Springer
Founder

Luca is an expert in network science and computational game theory. He also has a strong policy background with a focus on healthcare systems. Luca previously worked at Stockdale Street, where he gathered years of experience analyzing, investing in, and helping grow healthcare, consumer, and technology companies. He holds an MSc in Computer Science and an MSc in Global Governance from the University of Oxford where he studied as a Rhodes Scholar. Luca is a Schmidt Futures ISF Fellow.

Thomas Carroll
Founder

Clinical cancer researcher with a specialty in bioinformatics, biomarkers, and methods development. Passionate about building better diagnostics and putting a dent in cancer mortality.

Open roles 1

Diagnostics Clinical Lead
San Francisco, CA, US · Full-time · $120K - $220K · 0.10% - 0.20%
Apply ↗

Company timeline

Similar startups